Role of type 10 17beta-hydroxysteroid dehydrogenase in the pathogenesis of Alzheimer's disease.
Yang
S Y
SY
Department of Pharmacology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314, USA.
He
X Y
XY
D015067:17-Hydroxysteroid Dehydrogenases / Q000235:genetics / Q000378:metabolism*; D015094:3-Hydroxyacyl CoA Dehydrogenases / Q000378:metabolism*; D000429:Alcohol Oxidoreductases / Q000378:metabolism*; D000544:Alzheimer Disease / Q000201:enzymology*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D004721:Endoplasmic Reticulum / Q000201:enzymology; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D008928:Mitochondria / Q000201:enzymology; D008958:Models, Molecular; D009474:Neurons / Q000502:physiology; D011487:Protein Conformation; D013552:Swine; D014960:X Chromosome
D016229:Amyloid beta-Peptides; D015067:17-Hydroxysteroid Dehydrogenases; D000429:Alcohol Oxidoreductases; D015094:3-Hydroxyacyl CoA Dehydrogenases; C108634:HSD17B10 protein, human; C458480:Hsd17b10 protein, mouse; C044256:3 (or 17)-beta-hydroxysteroid dehydrogenase